The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2024 | A study investigating the impact of inherited variants on CLL prognosis
Susan Slager, PhD, Mayo Clinic, Rochester, MN, highlights a study investigating inherited variants associated with the prognosis of chronic lymphocytic leukemia (CLL). The study found that the inherited variants involved in CLL prognosis differ from those associated with its development. Dr Slager emphasizes how little work has been conducted in the area. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
